Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kewaunee Scientific (KEQU) EBT (2016 - 2026)

Kewaunee Scientific has reported EBT over the past 17 years, most recently at $1.6 million for Q1 2026.

  • Quarterly results put EBT at $1.6 million for Q1 2026, up 25.8% from a year ago — trailing twelve months through Jan 2026 was $16.1 million (up 79.52% YoY), and the annual figure for FY2025 was $14.8 million, up 12.7%.
  • EBT for Q1 2026 was $1.6 million at Kewaunee Scientific, down from $3.5 million in the prior quarter.
  • Over the last five years, EBT for KEQU hit a ceiling of $7.1 million in Q2 2025 and a floor of -$887000.0 in Q1 2022.
  • Median EBT over the past 5 years was $2.3 million (2022), compared with a mean of $2.5 million.
  • Biggest five-year swings in EBT: skyrocketed 1103.53% in 2023 and later crashed 63.73% in 2025.
  • Kewaunee Scientific's EBT stood at $456000.0 in 2022, then soared by 962.5% to $4.8 million in 2023, then dropped by 18.86% to $3.9 million in 2024, then dropped by 12.16% to $3.5 million in 2025, then crashed by 53.55% to $1.6 million in 2026.
  • The last three reported values for EBT were $1.6 million (Q1 2026), $3.5 million (Q4 2025), and $3.9 million (Q3 2025) per Business Quant data.